PAKIANATHAN DEEPIKA — SEC insider filings

SEC reporting owner CIK 1270734. 25 insider filings on record with FilingPulse; latest filed 2026-09-24.

Transaction summary — filings shown

Covers all 25 filings on record, filed 2021-04-29 to 2026-09-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Karyopharm Therapeutics Inc. (KPTI)Director9—18 legs · 2,263,006 sh · $5,100,5186
Mereo BioPharma Group plc (MREO)Director4—1 leg · 105,244 sh · $466,21015
Calithera Biosciences, Inc. (CALA)Director3—2 legs · 121,333 sh · $46,8102
Theravance Biopharma, Inc. (TBPH)Director7——21
PARDES BIOSCIENCES, INC. (PRDS)Director2——4

Insider filings — PAKIANATHAN DEEPIKA

FiledFormIssuerReported transactionsSource
2026-09-244Theravance Biopharma, Inc. (TBPH)Disposition to issuer (D): 58,065 · Disposition to issuer (D): 6,009 · Disposition to issuer (D): 17,000 (derivative) · Disposition to issuer (D): 6,000 (derivative) · Disposition to issuer (D): 28,000 (derivative) · Disposition to issuer (D): 22,044 (derivative) · +3 moreEDGAR
2026-06-164Theravance Biopharma, Inc. (TBPH)Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0EDGAR
2026-05-264Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 15,508 @ $0EDGAR
2026-02-274Mereo BioPharma Group plc (MREO)Grant/award (A): 66,000 (derivative) @ $0EDGAR
2025-05-294Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 4,600 (derivative) @ $0EDGAR
2025-05-214Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0EDGAR
2025-02-064Mereo BioPharma Group plc (MREO)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2024-08-234Mereo BioPharma Group plc (MREO)Option exercise (M): 1,825 @ $3 · Option exercise (M): 6,492 @ $1.84 · Option exercise (M): 12,418 @ $2.72 · Option exercise (M): 38,953 @ $1.31 · Option exercise (M): 43,485 @ $0.94 · Option exercise (M): 2,071 @ $3.87 · +7 moreEDGAR
2024-06-074Karyopharm Therapeutics Inc. (KPTI)Sale (S): 463,518 @ $0.96 · Sale (S): 4,526 @ $0.96 · Sale (S): 117,307 @ $0.98 · Sale (S): 1,145 @ $0.98 · Sale (S): 229,308 @ $0.95 · Sale (S): 2,240 @ $0.95EDGAR
2024-06-044Karyopharm Therapeutics Inc. (KPTI)Sale (S): 202,418 @ $0.95 · Sale (S): 1,976 @ $0.95 · Sale (S): 357,256 @ $1.00 · Sale (S): 3,488 @ $1.00 · Sale (S): 337,742 @ $0.95 · Sale (S): 3,298 @ $0.95EDGAR
2024-05-304Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 69,000 (derivative) @ $0EDGAR
2024-05-104Theravance Biopharma, Inc. (TBPH)Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0EDGAR
2024-02-094Mereo BioPharma Group plc (MREO)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2023-05-254Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 34,000 (derivative) @ $0EDGAR
2023-05-044Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,132 @ $0 · Grant/award (A): 22,044 (derivative) @ $0EDGAR
2023-01-314Calithera Biosciences, Inc. (CALA)Sale (S): 120,161 @ $0.39 · Sale (S): 1,172 @ $0.39EDGAR
2022-06-104Karyopharm Therapeutics Inc. (KPTI)Sale (S): 322,825 @ $6.50 · Sale (S): 3,152 @ $6.50 · Sale (S): 209,455 @ $6.18 · Sale (S): 2,045 @ $6.18 · Sale (S): 1,294 @ $6.00 · Sale (S): 13 @ $6.00EDGAR
2022-06-034Calithera Biosciences, Inc. (CALA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-05-204Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 23,900 (derivative) @ $0EDGAR
2022-04-284Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,852 @ $0 · Grant/award (A): 28,000 (derivative) @ $0EDGAR
2021-12-304/APARDES BIOSCIENCES, INC. (PRDS)Conversion (C): 30,000 @ $0 · Conversion (C): 30,000 (derivative) @ $0EDGAR
2021-12-284PARDES BIOSCIENCES, INC. (PRDS)Conversion (C): 52,500 @ $0 · Conversion (C): 52,500 (derivative) @ $0EDGAR
2021-06-144Calithera Biosciences, Inc. (CALA)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-05-214Karyopharm Therapeutics Inc. (KPTI)Grant/award (A): 23,900 (derivative) @ $0EDGAR
2021-04-294Theravance Biopharma, Inc. (TBPH)Grant/award (A): 9,828 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1270734 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs